| scholarly article | Q13442814 |
| P50 | author | J. Andrew McCammon | Q6104601 |
| P2093 | author name string | Steffen Lindert | |
| P2860 | cites work | Bio3d: an R package for the comparative analysis of protein structures. | Q46122078 |
| Are there non-trivial dynamic cross-correlations in proteins? | Q47879942 | ||
| Triclosan: applications and safety | Q71531505 | ||
| Enoyl-Acyl Carrier Protein Reductase (fabI) Plays a Determinant Role in Completing Cycles of Fatty Acid Elongation in Escherichia coli | Q71823957 | ||
| The origin of malignant malaria | Q24657620 | ||
| Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan | Q27619680 | ||
| Molecular basis for triclosan activity involves a flipping loop in the active site | Q27620673 | ||
| Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase | Q27637344 | ||
| Studies ofToxoplasma gondiiandPlasmodium falciparumenoyl acyl carrier protein reductase and implications for the development of antiparasitic agents | Q27643926 | ||
| X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition | Q27661938 | ||
| Structural basis of triclosan resistance | Q27666002 | ||
| Effect of substrate binding loop mutations on the structure, kinetics, and inhibition of enoyl acyl carrier protein reductase from Plasmodium falciparum | Q27666619 | ||
| Applying Molecular Dynamics Simulations to Identify Rarely Sampled Ligand-bound Conformational States of Undecaprenyl Pyrophosphate Synthase, an Antibacterial Target | Q27666848 | ||
| The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling | Q27860637 | ||
| UCSF Chimera--a visualization system for exploratory research and analysis | Q27860666 | ||
| The Amber biomolecular simulation programs | Q27860745 | ||
| Comparison of multiple Amber force fields and development of improved protein backbone parameters | Q27861040 | ||
| Estimates of the ab initio limit for pi-pi interactions: the benzene dimer | Q28220121 | ||
| Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes | Q29397708 | ||
| POVME: an algorithm for measuring binding-pocket volumes | Q30499011 | ||
| Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway | Q33314589 | ||
| Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques | Q33403707 | ||
| The GROMOS software for biomolecular simulation: GROMOS05. | Q34457783 | ||
| Discovery of a novel binding trench in HIV integrase. | Q34546744 | ||
| Enoyl reductases as targets for the development of anti-tubercular and anti-malarial agents. | Q36755772 | ||
| An improved relaxed complex scheme for receptor flexibility in computer-aided drug design | Q36838120 | ||
| Diversity in enoyl-acyl carrier protein reductases | Q37371673 | ||
| Molecular dynamics simulations of protein targets identified in Mycobacterium tuberculosis | Q37848858 | ||
| Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010). | Q37886187 | ||
| Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis | Q42538502 | ||
| Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan | Q42807024 | ||
| Evaluation of enoyl-acyl carrier protein reductase inhibitors as Pseudomonas aeruginosa quorum-quenching reagents. | Q43119498 | ||
| Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors | Q43816773 | ||
| Computational drug design accommodating receptor flexibility: the relaxed complex scheme | Q43992973 | ||
| The relaxed complex method: Accommodating receptor flexibility for drug design with an improved scoring scheme | Q44310443 | ||
| Structural basis for the variation in triclosan affinity to enoyl reductases | Q45069470 | ||
| P433 | issue | 11 | |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| drug discovery | Q1418791 | ||
| P304 | page(s) | 1734-1745 | |
| P577 | publication date | 2012-10-09 | |
| P1433 | published in | Protein Science | Q7251445 |
| P1476 | title | Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery | |
| P478 | volume | 21 |
| Q93016939 | Antimalarial Properties of Isoquinoline Derivative from Streptomyces hygroscopicus subsp. Hygroscopicus: An In Silico Approach |
| Q36729008 | Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase |
| Q34785012 | In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors |
| Q34503061 | POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics |
| Q28547385 | Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations |
Search more.